Explore FHI 360

Tools

Counseling Script for Contraceptive Injectables for Family Planning Providers

This evidence-based script, developed in Malawi, is for facility- and community-based family planning providers to counsel family planning clients on injectable contraception.

Project

Research on Scale-up of the Hormonal IUD in New and Emerging Markets (SHINE)

SHINE will generate evidence to inform the introduction and scale-up of the hormonal IUD and support future introduction of similar family planning methods.

Published research

“Men can take part”: Examining men’s role in supporting self-injectable contraception in southern Malawi, a qualitative exploration

Published research

Turned away and at risk: Denial of family planning services to women in Malawi

Published research

The provider role and perspective in the denial of family planning services to women in Malawi: A mixed-methods study

Publication

Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER): Newsletter

Malawi EMPOWER newsletters highlight the HIV prevention project's activities targeted to young women.

Project

Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER)

EMPOWER is an HIV prevention project, in support of the Government of Malawi’s commitment to HIV epidemic control, that targets young women in two districts in Malawi.

Published research

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

The authors found that women who self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) led to a more than 50 percent increase in pregnancy protection through 12 months compared with provider-administered injection. The findings demonstrate that self-injection can address the stubborn problem of early contraceptive discontinuation and that community health workers can safely train women to self-inject. Malawi plans to introduce DMPA-SC self-injection based on these positive findings.

News

FHI 360 study provides further evidence to support the use of self-injected contraceptives

New research published in The Lancet Global Health shows that self-injected contraceptives may increase the continued use of contraception among women in low-resource settings.

Tools

Promoting Evidence-based Vasectomy Programming

Vasectomy is among the most cost-effective and safest family planning methods for meeting the needs of men and women who desire to limit future births, but it is underused in low-resource settings.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Counseling Script for Contraceptive Injectables for Family Planning Providers

Research on Scale-up of the Hormonal IUD in New and Emerging Markets (SHINE)

“Men can take part”: Examining men’s role in supporting self-injectable contraception in southern Malawi, a qualitative exploration

Turned away and at risk: Denial of family planning services to women in Malawi

The provider role and perspective in the denial of family planning services to women in Malawi: A mixed-methods study

Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER): Newsletter

Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER)

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

FHI 360 study provides further evidence to support the use of self-injected contraceptives

Promoting Evidence-based Vasectomy Programming

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

14 Results Found

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial